Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Clinical trial NCT02228382 · TERMINATED
Trial details
- NCT number
- NCT02228382
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-07
- Primary completion
- 2020-10-13
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.